Key Takeaways
- Philips plans to sell its Bothell, Washington campus as part of a long‑term real‑estate strategy, emphasizing that the move will not affect current employees or operations.
- The Bothell site has a storied history in medical‑device innovation, originating from ATL Ultrasound, which Philips acquired in 1998 and turned into a global ultrasound hub.
- The campus also hosts legacy operations from Heartstream (automated external defibrillators) and contributed to the rise of SonoSite, another major ultrasound player later bought by Fujifilm.
- Recent challenges include a 2023 FDA warning letter citing documentation gaps in defect reporting at the Bothell facility, alongside layoffs affecting 33 workers in the healthcare‑device manufacturing unit.
- Philips intends to retain a local presence, seeking a new Bothell‑area site to relocate staff and operations if the property sells.
- The sale reflects broader portfolio reshaping at Philips, balancing cost‑effective real‑estate management with continued investment in the Pacific Northwest’s med‑tech ecosystem.
Philips Announces Intent to Sell Bothell Campus
In May 2026 Philips disclosed that it will list its current Bothell, Washington campus for sale. The decision stems from the company’s long‑term real‑estate and workplace‑planning strategy, which aims to align physical assets with evolving operational needs. Philips emphasized that the transaction will be a multi‑year process and that, should the property sell, it will secure another local site to which employees and operations can be relocated.
Campus Size and Workforce
As of the previous year, the Canyon Park facility—spanning several buildings at 22100 Bothell Everett Highway—employed roughly 1,500 individuals. This sizable workforce underscores the campus’s importance not only to Philips but also to the broader Seattle‑area medical‑device sector. The site hosts employees from multiple Philips business segments, with Ultrasound and Personal Health representing the largest groups.
Historical Roots: ATL Ultrasound
The Bothell campus traces its prominence to ATL Ultrasound, a pioneering medical‑imaging firm that helped place the Seattle region on the global ultrasound map. Philips acquired ATL in 1998 for approximately $800 million, subsequently transforming Bothell into a worldwide hub for its ultrasound business. Over the ensuing decades, Philips expanded its footprint in the area, building on ATL’s legacy of innovation and engineering excellence.
Spin‑offs and Ecosystem Impact
ATL’s influence extended beyond Philips; it helped seed a broader ultrasound ecosystem in Washington State. Notably, SonoSite emerged as an independent spin‑out from ATL before being acquired by Fujifilm in 2012 for $995 million. This trajectory illustrates how the Bothell site acted as a catalyst for multiple successful med‑tech ventures, reinforcing the region’s reputation as a center of imaging technology.
Heartstream and Defibrillator Legacy
Another cornerstone of the Bothell campus is Heartstream, the Seattle‑area pioneer in automated external defibrillators (AEDs). Heartstream was acquired by Hewlett‑Packard in 1998, later integrated into Agilent Technologies, and finally folded into Philips through Philips’ 2001 purchase of Agilent’s healthcare business. More recently, Bridgefield Capital revived the Heartstream brand as an independent company based in Bothell, employing about 600 people worldwide.
Recent Operational Challenges
Philips’ Bothell facility has faced scrutiny in recent years. In September 2023 the U.S. Food and Drug Administration issued a warning letter to Philips’ CEO, citing oversight concerns at the Bothell site (as well as locations in Pennsylvania and the Netherlands). The FDA noted insufficient documentation regarding how the company responds when ultrasound devices are reported defective or malfunctioning. Additionally, GeekWire reported that Philips carried out layoffs affecting 33 employees at its Bothell‑area healthcare‑device manufacturing plant in the preceding year.
Philips’ Assurance on Employment
Despite the impending sale, Philips stressed that the real‑estate transaction will have no impact on employee roles, employment status, or business operations in Bothell. A company spokesperson clarified that the move pertains solely to space alignment and real‑estate strategy, affirming that current staff will retain their positions. Philips also stated its intention to maintain a regional presence by securing a new local site to accommodate ongoing needs should the campus be sold.
Strategic Context: Portfolio Reshaping
The decision to divest the Bothell property aligns with Philips’ broader effort to reshape its healthcare portfolio and optimize its global footprint. By evaluating and potentially redeveloping underutilized or misaligned real‑estate assets, the company aims to redirect capital toward high‑growth areas such as diagnostic imaging, connected care, and personal health. The Bothell sale, therefore, forms part of a calculated approach to balance cost efficiency with continued investment in innovation‑critical locations.
Future Outlook for the Bothell Area
While the campus may change hands, the legacy of innovation cultivated at Bothell is likely to endure. Philips’ commitment to relocating operations locally suggests that the region will retain a significant med‑tech workforce and continue to benefit from the expertise cultivated over decades. Moreover, the independent revival of Heartstream and the ongoing presence of other ultrasound‑related entities signal that Bothell remains a fertile ground for medical‑device advancement, even as individual corporate assets shift ownership.